Clinical Trial News Archive
Get news by email or subscribe to our news feeds.
News Archive for July 2008
July 1, 2008
- ADVENTRX Announces Preliminary Response Rate Data From Discontinued Phase 3 Trial of CoFactor
- Halozyme Therapeutics Announces That Chemophase Meets Primary Endpoint in Phase I/IIa Clinical Trial
- Burnham Institute Researchers Link Early Stem Cell Mutation to Autism
- Bad News to Bad Bugs: Northern Antibiotics Develops Novel Polymyxins With Reduced Toxicity
- SuperGen Comments on Preliminary Efficacy Update on EORTC Phase 3 Trial of Dacogen Versus Supportive Care in Patients With Myelodysplastic Syndromes
- Journal of Clinical Oncology Publishes Leukine Study Demonstrating Positive Survival Outcomes in Patients with High-Risk Melanoma
- Cancer Cells Revert to Normal at Specific Signal Threshold, Stanford Researchers Find
- Results Published in the Journal 'Cancer' Demonstrate that Oral Talactoferrin Alfa is Active as Monotherapy in Previously Treated Patients with Metastatic Renal Cell Carcinoma
- Oculus Innovative Sciences Announces Positive Results from Abstract Evaluating the Use of Microcyn(R) Technology in Treatment of Atopic Dermatitis
- Alkermes Presents Positive Data on Proprietary Molecules Targeting Opioid Receptors
- Yeast-Based Vaccine Induces Immune Responses and Reduces Tumor Size in Mice
- arGentis Files Patent on Nucleic Acid Sequences and Polymorphisms Predictive of Patient Responses to ARG201 an Immunotherapy for Late Phase Systemic Sclerosis
- 'Hibernation-On-Demand' Drug Hydrogen Sulfide Significantly Improves Survival After Extreme Blood Loss
- Eisai Provides Preliminary Efficacy Update On EORTC Phase III Trial of Dacogen Versus Supportive Care in Patients With Myelodysplastic Syndromes
- Pediatric Researchers Find Possible 'Master Switch' Gene in Juvenile Arthritis
- Since Introduction of Highly Active Antiretroviral Therapy, Death Rate for HIV-infected Persons Has Decreased
July 2, 2008
- Titan Pharmaceuticals Announces Spheramine Initial Phase IIb Results
- ExonHit Presents Therapeutic and Diagnostic Programs for Alzheimer's at ICAD 2008
- Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML)
- FDA Updates Atripla Package Insert
- MicroIslet Provides Safety and Efficacy Data Update
- Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer
- Controlling Bone Disease Improves Survival of Hemodialysis Patients
July 3, 2008
- ARYx Therapeutics, Inc. Announces Successful Results of QT Study on ATI-7505
- New Research Indicates That Adrenal Nodules Not Being Adequately Evaluated
- Vavelta: Phase II Data Presented at Face and Commercial Sales Commenced
- Resolvyx Scientific Advisors Publish First In-Vivo Data Showing Resolvins Suppress IL-23 and IL-17, Key Mediators of Inflammatory Disease
- Evotec's EVT 101 Well Tolerated in Four Week Higher Repeat Dose Safety Study
- Blood Vessel Inhibitor Shows Promise Against Metastatic Thyroid Cancer Researchers Also Find Evidence Tying a Genetic Mutation to Clinical Outcome
- Phase III ARISER Study with Rencarex: Patient Recruitment Successfully Completed
- Medivation to Host Conference Call at 5 p.m. EDT Monday to Discuss Top-Line Phase 2 Study Results in Huntington's Disease
July 7, 2008
- Teva Provides Update on Forte Trial
- Complete Study Results Comparing CTI's Opaxio With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology
- BrainStorm Cell Therapeutics and Rutgers University Study Shows That Transplanting NTF Cells Improves the Recovery of Spinal Cord Injury Rat Model
- Early Findings Show Promise as AS1411 AML Study Proceeds to Higher-dose Stage
- Suven Life Sciences Clinical candidate SUVN-502 Being Presented at International Conference on Alzheimer’s Disease, ICAD-2008 at Chicago, USA
- Advitech Announces Positive Clinical and Pre-Clinical Results
- Probiodrug to Present Novel Causative Treatment Approach for Alzheimer’s Disease QC Inhibition To Be Discussed at Alzheimer's Association International Conference on Alzheimer's Disease (ICAD) 2008
- ReGen Biologics Announces JBJS Publication of Successful Clinical Trial Results for its Meniscus Product
- Xclair Reported to Be Safe and Effective in Study Published in European Journal of Dermatology
- New Treatment Strategy Can Beat Depression in Cancer Patients (SMaRT Oncology 1 Trial)
- Gender is an Issue in Kidney Transplantation
- New Drugs for Crohn’s Disease
- Kidney Cancer Patients Given Vaccine Show No Increased Survival
- GeoVax Reports Progress on Its AIDS Vaccine Technology
- Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeich's Genous Bio-engineered R Stent Has Better Outcomes When Compared to Drug-Eluting Stents
- Embryo Viability Studies Support Utility of Novel, Metabolomic Profiling Technology
- St. Jude Study Reveals a New Function for an Old Enzyme in Fatal Childhood Disease
- Patients More Likely to Stay on Lipitor Than Simvastatin, a Large Observational Study Shows
July 8, 2008
- Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntington's Disease
- New study reveals Caduet two-in-one pill dramatically improves patient adherence
- LifeCycle Pharma Announces Positive Topline Results from Phase II Clinical Study of LCP-Tacro Once Daily in Stable Liver Transplant Patients
- Some Antidepressants Associated with Gastrointestinal Bleeding
- Head-to-Head Study Demonstrates Focalin XR Offers Faster and Better Symptom Control than Concerta in Early Part of ADHD Patients' Day
- Sciele Pharma Completes Phase III Safety Trial for Glycopyrrolate Liquid, a Treatment for Chronic, Moderate-to-Severe Drooling in Pediatric Patients
- Emisphere Announces Data From Independent Clinical Study of Effects of Oral GLP-1 on Glucose and Insulin Concentrations
- Study Measures Real-World Comparative Effectiveness of Asthma Controller Medications
- Schering-Plough Announces Phase III Data for Sustained Follicle Stimulant
- Introgen to Host Conference Call with Clinical Investigators to Discuss Phase III Data and Advexin Registration Activities
July 9, 2008
- Androgen Deprivation Therapy for Localized Prostate Cancer Not Associated with Improved Survival
- Welichem Succesfully Completes Phase I Clinical Trial
- Lorus Therapeutics Provides an Update on Progress in Virulizin Development Program
- Compugen Announces Positive In-Vivo Results for Therapeutic Peptide Candidate for Immune Related Diseases
- Polyphor Successfully Completes Phase I Clinical Trials of POL6326
- Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
- Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
- Icagen Successfully Completes Phase I Multiple Ascending Dose Clinical Trial of Senicapoc
- Aradigm to Hold Business Update Conference Call on July 16
- Kidney Disease Linked to Lower Medication Use After Heart Attack
July 10, 2008
- CYT003-QbG10 Monotherapy for the Treatment of Allergic Diseases is Safe and Efficacious in Placebo-controlled Phase II Study
- Sosei Announces Completion of Phase III Trial for NorLevo
- Bioniche Presents E. coli O157:H7 Vaccine Data to World Buiatrics Congress in Budapest, Hungary
- Prostate Cancer Vaccines more Effective with Hormone Therapy
- Novel Approach May Protect Against Heart Attack Injury
- Common Mechanisms May Underlie Autism's Seemingly Diverse Mutations
July 11, 2008
- Mesoblast Limited Announce Pre-clinical Trials Show Allogenic Stem Cells Effectively Treat Eye Diseases
- Repros Therapeutics Inc. Announces That Proellex Significantly Reduces Pain in a U.S. Phase 2 Clinical Trial in Women with Moderate to Severe Endometriosis
- Pharming Announces Positive Results From Rhucin Open-label Clinicial Studies
- Neuron to Publish Prana's PBT2 Preclinical Research
- Mesoblast Limited (ASX:MSB) Announce Pre-clinical Trials Show Allogenic Stem Cells Effectively Treat Eye Diseases
- Oxford BioMedica Announces Data Safety Monitoring Board Recommendation for Trovax PHASE III Trist Study
July 14, 2008
- Cyclacel Publishes Study of Seliciclib Synergy with Tarceva and Herceptin in Journal Clinical Cancer Research
- Cardiome to Hold Conference Call
- ADAGIO Phase III Top Line Data to be Presented at 12th Congress of European Federation of Neurological Societies
- Eight-Year Melanoma Remission is Among Early Cancer Treatment Results
- Vical to Present Phase 1 Data for Vaxfectin-Formulated Pandemic Influenza DNA Vaccines
- Pegylated Interferon Alfa-2b Improves Recurrence-free Survival in Melanoma Patients
- Now More Than Ever, Improved TB Vaccines Urgently Needed
- Preventive Malaria Treatment Lowers Anaemia Prevalence and Improves Attention Span of School Children
- NanoViricide's EKC Eye Drug Candidate Stopped Clinical Conjunctivitis Pathology
- New Publication Shows Cleviprex is Effective for Rapid Treatment of Acute Hypertension After Cardiac Surgery
- Cardiome Announces Positive Phase 2b Results For Oral Vernakalant
- Amgen Announces Positive Top-Line Results for Denosumab Treatment of Bone Loss in Men With Non-Metastatic Prostate Cancer Undergoing Androgen Deprivation Therapy
- Amgen Announces Positive Top-Line Results for Denosumab Treatment of Bone Loss in Men With Non-Metastatic Prostate Cancer Undergoing Androgen Deprivation Therapy
- Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival - Jul 14, 2008
- Alkermes Presents Positive Preclinical Data on Naltrexone for Extended-Release Injectable Suspension at Annual Meeting of Controlled Release Society
- Pfizer to Showcase Alzheimer's Research and Pipeline at Upcoming Alzheimer's Disease Medical Meeting
- Genaera Corporation Presents Data on Mechanism of Inhibition of PTP-1B for Trodusquemine (MSI-1436) at Federation of American Societies for Experimental Biology (FASEB) Meeting
July 15, 2008
- Theravance Announces Positive Phase 2 Clinical Results in the MABA Respiratory Program for the Treatment of COPD
- XOMA 052 Phase 1 Data to be Presented At European Association for the Study of Diabetes Annual Meeting
- New Survey Findings Reveal Emotional and Physical Toll of Rheumatoid Arthritis and the Advancement of Treatment Through 'Generations'
- Study Examines Anti-clotting Therapy Following Cardioembolic Stroke
- Cardiome Announces Positive Phase 2b Results For Oral Vernakalant
- Journal of Clinical Oncology Publishes Study of Cephalon Medication Treanda Plus Rituximab in Relapsed Non-Hodgkin's Lymphoma
- IRX Therapeutics to Present Phase 2 Results at 7th International Conference on Head and Neck Cancer
July 16, 2008
- Vitamin K deficiency may be a significant risk factor for low bone mass in healthy children and in those with juvenile arthritis
- Study Showed Half of Patients Treated with Enbrel (etanercept) Plus Methotrexate Can Achieve DAS Clinical Remission and 80 Percent Had No Progression of Joint Damage in Active Early Rheumatoid Arthritis
- MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion
- Inovio Biomedical's First Proprietary DNA Vaccine Achieves 100% Protection Against Avian Flu in Pre-Clinical Testing
- Statin Does Not Appear Helpful for Children with Learning Disabilities Caused by Genetic Disorder
- Optimer Pharmaceuticals Announces Positive Results in Prulifloxacin Phase 3 Study
- MIV Provides Update on Its Next-Generation, Ultra-Thin Protea Stent Platform
- Researchers Discover Link Between Organ Transplantation and Increased Cancer Risk
- URGENT Study Provides Important New Insight into the Use of Dyspnea as a Clinical Endpoint for Evaluating New Treatments for Acute Heart Failure Syndromes
- Insightful Corporation Announces Webinar on "Graphical Evaluation for Cardiovascular Safety Data in Clinical Trials"
- MaxCyte to Present Scalable Clinical and Commercial Manufacturing Technology for Cell-based and Viral-based Vaccines
July 17, 2008
- Biojector 2000 Data Presented in Vical's Pandemic Influenza DNA Vaccine Human Trial
- Vical Announces Breakthrough for Pandemic Influenza DNA Vaccines With Preliminary Human Data
- Introgen to Present ADVEXIN Phase 3 Study Results at American Association for Cancer Research's Cancer Clinical Trials and Personalized Medicine Conference
- Bradmer Reports Progression Free Survival Data from Previous Phase II Glioblastoma Multiforme Trials
- Repros Therapeutics Inc. Announces That Proellex Administered to Patients as Cyclic Therapy to Treat the Symptoms of Uterine Fibroids for Up to 30 Months Shows No Adverse Effects on the Endometrium
- Published Study Demonstrates Lower Serum Creatinine Levels after Contrast Media Administration with Iodixanol Than with Iopromide
- BioNumerik Pharmaceuticals Observes Evidence of a Survival Increase in Lung Cancer Patients Participating in Tavocept Clinical Trial
- Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject Program
- Advanced Life Sciences Announces Collaboration With UK Ministry of Defence on ALS-886
- Ardea to Present Data on Lead HIV Candidate, RDEA806, at XVII International AIDS Conference
- Biovest Reports Results for Patients Treated with Anti-Cancer Vaccine: BiovaxID Demonstrates Clinically and Statistically Significant Improvement of Disease-Free Survival in Non-Hodgkin's Lymphoma in Pivotal Phase 3 Clinical Trial
- Nemours Center for Childhood Cancer Research Team at the Alfred I. duPont Hospital for Children Identifies the Function of a Biomarker Present in Prostate Cancer Cells: New Insight into Therapeutic Benefit for Patients with Advanced Prostate Cancer
July 18, 2008
- Medivation Announces Publication in The Lancet of Dimebon Pivotal Trial Results in Alzheimer's Disease
- Resverlogix's Lead Drug Featured in Key Scientific Publication
- Repros Therapeutics Inc. Announces That Initial Findings for Proellex Show No Tumorigenic Response in a Two-year Carcinogenicity Study in Rats
July 21, 2008
- NSL-043 Achieves Success in Phase I Multiple Ascending Dose Trial
- Repros Therapeutics Inc. Announces That the Results of the European Trial Demonstrating Uterine Fibroid Size Reduction in Patients Administered Proellex(R) Will Be in Print in August 2008
- Verto, a Subsidiary of Hadasit Bio-Holdings, Completes Successful Human Clinical Trial of a Treatment for Lupus
- Update on the SEAS Study
- Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study
- Paper in Molecular Cancer Therapeutics Reports that a Novel Combination of Alfacell's Onconase and Rosiglitazone Induces a Synergistic Apoptotic Effect in Several Cancer Cell Lines
- Independent Analyses of the SEAS, SHARP and IMPROVE-IT Studies of Ezetimibe
- High Hopes for New Treatments at Fragile X International Conference
July 22, 2008
- Elan and Wyeth Announce Webcast to Discuss Bapineuzumab Phase 2 Clinical Trial Results
- Plants Make Vaccine for Treating Type of Cancer in Stanford Study
- Opexa Conducts Additional Analysis on Phase I/II Extension Study with Tovaxin for Multiple Sclerosis
- Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models
- Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes
- Claire SkyePharma Announces Positive Results for Two European Studies for Flutiform
- New Paper Published in "Stem Cells" Reporting In-Vivo Migration Ability of Brainstorm Cell Therapeutics' NTF Cells
- Final Results From Phase 2 Clinical Trial of GVAX Immunotherapy for Prostate Cancer Published in the American Cancer Society's Journal Cancer
- Epilepsy Drug May Increase Risk of Birth Defects
- Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus
- BTG plc: Study Shows Abiraterone Can Successfully Treat Aggressive, Chemotherapy-Resistant Prostate Cancer
- BioNeutral Confirms Broad Spectrum Efficacy with Its Ygiene Antimicrobial
- Verto, a Subsidiary of Hadasit Bio-Holdings, Completes Successful Human Clinical Trial of a Treatment for Lupus
- Experts Available to Discuss Study on Silent Strokes
- IRX Therapeutics Announces Results of Phase 2 Study for IRX-2
- YM Biosciences Presents Data Comparing Mechanism of Action for EGFR Antibody, Nimotuzumab to Cetuximab and Panitumumab, at the Aacr Centennial Conference on Translational Cancer Medicine 2008
- Once Suspect Protein Found to Promote DNA Repair, Prevent Cancer
- New Study Shows Drug Combats Previously Untreatable Prostate Cancers
- Helicon Study of HT-0712 on Primate Memory Formation Reveals Significant Enhancement
July 23, 2008
- ZIOPHARM Presents Safety and Preliminary Efficacy Data from Two Phase I Studies of Indibulin at AACR Centennial Conference
- Advexin Shows Statistically Significant Six-Month and Overall Survival Benefit as Compared to Methotrexate in Prospectively Defined Biomarker Patient Population
- Use of Sildenafil Associated with Improvement in Antidepressant-related Sexual Dysfunction in Women
- FluoroPharma Announces Positive Phase I Safety Results for BFPET, Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET)
- SWCRF Researcher Identifies Ways to Significantly Expand the Applicability of a Unique Anti-Cancer Drug
- InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs
July 24, 2008
- NEJM Publishes Nexavar Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer
- NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension
- Isentress (raltegravir), Merck's First in Class Integrase Inhibitor, Suppressed HIV-1 Viral Load and Increased CD4 Cell Counts through 48-Weeks in Treatment-Experienced Adult Patients When Taken with Other Anti-HIV Medicines
- Biodel Announces Publications Demonstrating Superior Metabolic Profile of VIAject Compared to the Rapid-acting Analog Humalog and Regular Human Insulin in Healthy Volunteers and Compared to Regular Human Insulin in Patients with Type 1 Diabetes
- MacroChem Announces Phase 2 Data for EcoNail in the Treatment of Onychomycosis
- 'Statins' Linked to Improved Survival in Kidney Transplant Recipients
- Alizyme Announces Headline Results from Its European Phase III Clinical Trial of Colal-Pred in Patients with Moderate to Severe Ulcerative Colitis
- Webcast Alert: JAMA Media Briefing on HIV/AIDS
- Cancer Treatment Application of the Aethlon Hemopurifier Published in Journal of Translational Medicine
- Studies Assessed by European Health Authority Conclude That Impurity in Roche’s Viracept (nelfinavir Mesylate) Did Not Increase Patients’ Risk of Cancer
July 25, 2008
- Journal of Clinical Oncology Article Highlights CellSearch Circulating Tumor Cell Test in Treatment of Metastatic Colorectal Cancer
- Genaera Releases Phase 1 Data and New Preclinical Data on the CNS Function of Trodusquemine (MSI-1436) at CBI Obesity Summit
- Study Confirms that Levitra on Demand is Effective in Patients with ED after Nerve-sparing Prostatectomy
- BG Medicine Announces Publication of Biomarker Signature of Atherosclerotic Plaque Rupture
- Prana Biotechnology Announces Conference Call Following ICAD Presentation - July 31, 2008 at noon EDT (USA)
July 28, 2008
- Nventa Announces Final Data from HspE7 Phase 1 Cervical Dysplasia Trial
- BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting
- Exforge Helps Nearly Twice as Many Patients Control Their High Blood Pressure Compared to Amlodipine Alone
- Amgen Announces Positive Top-Line Results for Denosumab Pivotal Postmenopausal Osteoporosis Trial
- New Research on Pre-Eclampsia in Mice May Have Important Implications for Humans
- Head-to-head Study Results Demonstrated No Significant Difference Between NicoDerm CQ and Chantix (Varenicline Tartrate) in Long Term Quit Rates
- InCode BioPharmaceutics, Inc. Announces Key Safety Data for rC3-1: A New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Two New Alzheimer's Disease Studies Show Advances Against Different Treatment Targets
July 29, 2008
- Ardea to Present Data on Lead HIV Candidate, RDEA806, at ICAAC/IDSA Joint Meeting
- Inspire Provides Update on Cystic Fibrosis Clinical Program
- Valens Pharma Reports Top-Line Results from Voluntary Phase II Trial
- Tumor Targeting Docetaxel Abstract Presented at the 11th Liposome Research Days Conference
- OctoPlus Proves Efficacy of OP-145 in Phase II Ear Infection Study
- Titan Pharm Announces Positive Ph 3 Probuphine Opioid Addiction Treatment Results
- Discovery Labs KL-4 Surfactant Anti-Inflammatory Data Published in Pediatric Research
- Findings on Bladder-Brain Link May Point to Better Treatments for Problems in Sleep, Attention
- Older Treatment May be More Effective in Preserving Sight For Some Patients With Diabetes
July 30, 2008
- High Statin Doses Do Not Impair Aerobic Activity or Skeletal Muscle Function in Older Adults, Says New Study
- Preliminary Cerepro Phase III Results Meet Primary Endpoint
- Acorda Therapeutics Presents Positive Data from Preclinical Studies of Neuregulins in Cardiac Function
- Markers in Blood and Spinal Fluid, and a New Imaging Agent, Show Promise for Early Detection of Alzheimer's
- Elan and Wyeth Present Encouraging Results from Phase 2 Clinical Trial of Bapineuzumab at International Conference on Alzheimer`s Disease
- Four Alzheimer's Clinical Trials Address a Variety of Treatment Targets - Amyloid, Tau, Synapse Formation
- Precise Low-Dose Drug Monitoring Essential for Long-Term Kidney Transplant Success
- Early Study Reveals New Drug Could Improve Executive Function in Alzheimer's Patients
- Elan and Wyeth Present Encouraging Results from Phase 2 Clinical Trial of Bapineuzumab at International Conference on Alzheimer's Disease
- Laboratory and Mouse Studies Show Targeted Drug Blocks the Growth of Breast Cancer Cells that Spread to the Brain
- New Data Highlight Positive Results of Namenda (memantine HCl) Once-Daily Extended-Release Formulation
- Published Study Shows Oxycyte Successfully Reduces Oxygen Shortages in a Spinal Cord Injury Model
- First Ever Study on Alzheimer's Disease Treatment in Hispanics Presented at Major Medical Meeting
- Medivation Presents Positive New Data on Dimebon's Long-Term Efficacy and Novel Mechanism of Action at the International Conference on Alzheimer's Disease
- Alzheimer's Foundation of America Survey: Americans With Memory Concerns Fall Short of Talking to Doctors
July 31, 2008
- Phase II Data on Lilly's Antibody Show it Affects Amyloid Beta, a Protein Believed to be Associated with Alzheimer's Disease
- Lifestyle Factors Contribute to Lowering and Raising Risk of Alzheimer's Disease
- Diverse Approaches to Alzheimer's Therapies Continue to Show Progress at ICAD
- Oramed Pharmaceuticals to Hold Conference Call on August 6 to Present Results of Phase 2A Oral Insulin Capsule Clinical Trials
- Memory Pharmaceuticals Presents Positive Preclinical Data for MEM 68626 at ICAD 2008
- Medivation Presents Positive New Data on Dimebon's Long-Term Efficacy and Novel Mechanism of Action at the International Conference on Alzheimer's Disease
- Medivation Presents Positive New Data on Dimebon's Long-Term Efficacy and Novel Mechanism of Action at the Interantional Conference on Alzheimer's Disease
- Anavex Presents Neuroprotective Effects of ANAVEX 1-41 at the International Conference on Alzheimer's Disease 2008
- Micro RNA Implicated as Molecular Factor in Alcohol Tolerance
- Mechanism for Postpartum Depression Found in Mice Discovery May Lead to Better Treatments
- Genmab and GlaxoSmithKline Announce Positive Top-Line Results in Ofatumumab Chronic Lymphocytic Leukemia Pivotal Study
- Treatment Corrects Severe Insulin Imbalance in Animal Studies
